Imaging biomarkers predict response to Anti-HER2 (ErbB2) therapy in preclinical models of breast cancer

Chirayu Shah, Todd W. Miller, Shelby K. Wyatt, Eliot T. McKinley, Maria Graciela Olivares, Violeta Sanchez, Donald D. Nolting, Jason R. Buck, Ping Zhao, M. Sib Ansari, Ronald M. Baldwin, John C. Gore, Rachel Schiff, Carlos L. Arteaga, H. Charles Manning

Research output: Contribution to journalArticlepeer-review

77 Scopus citations

Fingerprint

Dive into the research topics of 'Imaging biomarkers predict response to Anti-HER2 (ErbB2) therapy in preclinical models of breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences